البريد الإلكتروني: bd@sidmexinovia.com
رقم الهاتف: +918866862020
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
Heading 4
الرئيسية >
Olimab 60 mg PFS
Olimab 60 mg PFS
Manufacturer/Marketed By : Intas Pharmaceuticals Ltd
$169.88 $149.59
Olimab 60 mg PFS is a specialized medication designed to combat osteoporosis in men and postmenopausal women who are at an elevated risk for fractures, particularly those who have not...
Collapsible text is perfect for longer content like paragraphs and descriptions. It's a great way to give people more information while keeping your layout clean. Link your text to anything, including an external website or a different page. You can set your text box to expand and collapse when people click, so they can read more or less info.
Denosumab 60 mg
Active Pharmaceutical Ingredient
Olimab 60 mg PFS
169.88 US$
149.59 US$
Olimab 60 mg PFS is a specialized medication designed to combat osteoporosis in men and postmenopausal women who are at an elevated risk for fractures, particularly those who have not found relief with other osteoporosis treatments. This innovative therapy also addresses bone loss in men diagnosed with prostate cancer and women undergoing breast cancer treatment, both of which can lead to significant bone weakening. By working to strengthen bone density, Olimab significantly reduces the likelihood of fractures, especially in patients with bone cancer or multiple myeloma, a type of blood cancer. It’s crucial for patients to discuss any existing medical conditions and current medications with their healthcare provider, as this will ensure the safe use of Olimab. Regular monitoring for potential side effects, including any unusual changes in bone health, is recommended while on this treatment. With its targeted approach, Olimab 60 mg PFS plays a vital role in managing bone health, promoting stronger bones and reducing fracture risks in vulnerable populations. Always consult with a healthcare professional to determine if Olimab is the right choice for your specific health needs.
Active Pharmaceutical Ingredient
الاستخدامات
• Olimab 60 mg pfs is primarily indicated for the treatment of osteoporosis, a condition characterized by weakened bones and decreased bone density. It is particularly beneficial for men and postmenopausal women who are at a heightened risk for fractures. Patients who have not achieved adequate results from other osteoporosis medications may find Olimab 60 mg pfs to be a suitable alternative. This treatment aims to enhance bone strength and reduce the likelihood of fractures.
• Another significant use of Olimab 60 mg pfs is in managing osteolytic bone metastases associated with solid tumors. This includes men diagnosed with prostate cancer and women with breast cancer, conditions that often lead to bone loss due to certain treatments. By addressing the bone loss caused by cancer therapies, Olimab 60 mg pfs helps maintain bone integrity and overall quality of life. This supportive care is crucial for patients undergoing treatment for these cancers.
• Olimab 60 mg pfs is also utilized in patients experiencing significant bone density loss due to underlying health conditions or treatments. It can be an effective option for individuals whose bone health is compromised, particularly those receiving therapies that adversely affect bone metabolism. By incorporating Olimab 60 mg pfs into their treatment regimen, patients may experience improved bone health and a reduction in fracture risk. This makes it a vital part of comprehensive care for at-risk populations.
• In addition to its primary indications, Olimab 60 mg pfs may be used in various clinical settings where bone health is a concern. Healthcare providers often consider it for patients facing challenges with bone density, especially when previous treatments have not provided sufficient benefits. The use of Olimab 60 mg pfs can be pivotal in managing the complications associated with bone loss, ultimately supporting better health outcomes for affected individuals. This versatility makes it an important medication in the realm of bone health management.
فوائد
Olimab 60 mg PFS has been shown to be effective in reducing the risk of fractures in patients with osteoporosis and increasing bone density and strength, resulting in a lower risk of fractures in the spine, hip, and other bones. Olimab 60 mg is effective in reducing the risk of fractures in patients with bone metastases (spread of cancer to the bones).
تأثيرات جانبية
Anti-bone-loss Drug Olimab may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
الآثار الجانبية الأكثر شيوعًا
• Arm or leg pain
• Joint pain
• Muscle or bone pain
• Constipation,
• Abdominal discomfort
• Hair loss
• Skin rash
• Tingling, pain, or numbness that moves down your leg
الآثار الجانبية الشائعة
• Upper respiratory tract infection
• Frequent or painful urination, blood in urine, inability to hold urine
• Musculoskeletal
• Severe leg or joint pain
كيفية الاستخدام
Olimab 60 mg PFS can be administered to you subcutaneously (under the skin) by a doctor or nurse. You should also take calcium and vitamin D supplements while being on treatment with Anti-bone-loss Drug Olimab. Your doctor will decide the correct dose and duration for you depending on your age, body weight and disease condition.
نصائح السلامة
• Alcohol: It is generally not recommended to drink alcohol while taking Olimab 60 mg PFS. It may increase the risk of liver damage. it is best to avoid alcohol or limit your alcohol consumption while taking any medication.
• Kidney: Olimab 60 mg PFS should be used with caution in patients having severe kidney problems. Patients with severe kidney impairment (creatinine clearance < 30 mL/min) or receiving dialysis are at greater risk of developing hypocalcaemia. Consult your doctor before receiving Olimab 60 mg.
• Breastfeeding: It is not known whether Olimab 60 mg PFS passes into breast milk. If you are breastfeeding and taking Olimab 60 mg it is important to talk to your doctor about the potential risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Olimab 60 mg PFS should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Olimab 60 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Olimab 60 mg PFS may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Olimab 60 mg PFS may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Denosumab Injection 60 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Olimab 60 mg PFS has no or negligible influence on the ability to drive and use machines.
تنصل
تسعى شركة Sidmex Inovia جاهدة لتوفير معلومات دقيقة وموثوقة؛ ومع ذلك، فإن جميع المحتويات الموجودة على هذا الموقع الإلكتروني، بما في ذلك أوصاف المنتجات ومكوناتها، هي لأغراض إعلامية فقط ولا ينبغي اعتبارها بديلاً عن المشورة الطبية المهنية أو التشخيص أو العلاج.
يُنصح المستخدمون باستشارة أخصائي رعاية صحية مؤهل قبل اتخاذ أي قرارات طبية. لا ينبغي استخدام المعلومات المقدمة للتشخيص الذاتي أو العلاج الذاتي.
جميع المنتجات المذكورة مخصصة حصراً لأغراض التعاملات التجارية بين الشركات والاستفسارات بالجملة. لا تشجع شركة سيدمكس إينوفيا الاستخدام المباشر من قبل المستهلكين، وتهدف إلى دعم العلاقة بين أخصائي الرعاية الصحية والمريض، لا استبدالها.
جميع أسماء المنتجات والعلامات التجارية والأسماء التجارية مملوكة لأصحابها، ولا يعني استخدامها أي انتماء أو تأييد. لا تتحمل شركة سيدمكس إينوفيا أي مسؤولية عن أي تبعات ناتجة عن استخدام المعلومات الواردة في هذا الموقع الإلكتروني.